(Q43837277)

English

Multicenter phase II-III study of oxaliplatin plus cyclophosphamide vs. cisplatin plus cyclophosphamide in chemonaive advanced ovarian cancer patients

scientific article published in October 2001

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Multicenter phase II-III study of oxaliplatin plus cyclophosphamide vs. cisplatin plus cyclophosphamide in chemonaive advanced ovarian cancer patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

J L Misset

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

P Vennin

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

P H Chollet

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

P Pouillart

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

P H Laplaige

5

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

J L Frobert

6

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

D Castera

7

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

M Fabro

8

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

D Langlois

9

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

E Cortesi

10

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

V Lucas

11

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

E Gamelin

12

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

A Laadem

13

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

J Otero

14

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

publication date

1 October 2001

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1411-1415

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Cytotoxicity, cellular accumulation and DNA binding of oxaliplatin isomers.

1 reference

https://api.crossref.org/works/10.1023/A:1012556627852

7 January 2021

based on heuristic

inferred from DOI database lookup

Oxaliplatin, tetraplatin, cisplatin, and carboplatin: spectrum of activity in drug-resistant cell lines and in the cell lines of the National Cancer Institute's Anticancer Drug Screen panel

1 reference

https://api.crossref.org/works/10.1023/A:1012556627852

7 January 2021

based on heuristic

inferred from DOI database lookup

Single agent activity of oxaliplatin in heavily pretreated advanced epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1023/A:1012556627852

7 January 2021

based on heuristic

inferred from DOI database lookup

Oxaliplatin or paclitaxel in patients with platinum-pretreated advanced ovarian cancer: A randomized phase II study of the European Organization for Research and Treatment of Cancer Gynecology Group.

1 reference

https://api.crossref.org/works/10.1023/A:1012556627852

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced MLH1 expression in breast tumors after primary chemotherapy predicts disease-free survival

1 reference

https://api.crossref.org/works/10.1023/A:1012556627852

7 January 2021

based on heuristic

inferred from DOI database lookup

Enrichment for DNA mismatch repair-deficient cells during treatment with cisplatin

1 reference

https://api.crossref.org/works/10.1023/A:1012556627852

7 January 2021

based on heuristic

inferred from DOI database lookup

A call for change in anticancer drug evaluation

1 reference

https://api.crossref.org/works/10.1023/A:1012556627852

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

1 reference

https://api.crossref.org/works/10.1023/A:1012556627852

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage III or IV ovarian cancer: a gynecologic oncology group study

1 reference

https://api.crossref.org/works/10.1023/A:1012556627852

7 January 2021

based on heuristic

inferred from DOI database lookup

Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer

1 reference

https://api.crossref.org/works/10.1023/A:1012556627852

7 January 2021

based on heuristic

inferred from DOI database lookup

Mature results of a randomized trial of two doses of cisplatin for the treatment of ovarian cancer. Scottish Gynecology Cancer Trials Group

1 reference

https://api.crossref.org/works/10.1023/A:1012556627852

7 January 2021

based on heuristic

inferred from DOI database lookup

Pilot study of the paclitaxel, oxaliplatin, and cisplatin combination in patients with advanced/recurrent ovarian cancer

1 reference

https://api.crossref.org/works/10.1023/A:1012556627852

7 January 2021

based on heuristic

inferred from DOI database lookup

hMLH1 expression and cellular responses of ovarian tumour cells to treatment with cytotoxic anticancer agents

1 reference

https://api.crossref.org/works/10.1023/A:1012556627852

7 January 2021

based on heuristic

inferred from DOI database lookup

Oxaliplatin and paclitaxel combination in patients with platinum-pretreated ovarian carcinoma: An investigator-originated compassionate-use experience

1 reference

https://api.crossref.org/works/10.1023/A:1012556627852

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/A:1012556627852

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43837277&oldid=2103767816"